Pralnacasan

Names

[ CAS No. ]:
192755-52-5

[ Name ]:
Pralnacasan

[Synonym ]:
Pralnaan [INN]
HMR 3480
Pralnaan
Pralnaan (USAN/INN)
UNII-N986NI319S

Biological Activity

[Description]:

Pralnacasan (VX-740) is a potent, selective, non-peptide and orally active interleukin-1β converting enzyme (ICE, caspase 1) inhibitor with a Ki of 1.4 nM. Pralnacasan inhibits proinflammatory cytokines IL-18, IL-1β , and IFN-γ. Pralnacasan has the potential for osteoarthritis and rheumatoid arthritis treatment[1][2].

[Related Catalog]:

Signaling Pathways >> Apoptosis >> Caspase

Research Areas >> Inflammation/Immunology

[Target]

Interleukin-1β converting enzyme:1.4 nM (Ki)

[In Vivo]

Pralnacasan (0 -50 mg/kg; oral gavage; twice a day; for 6 weeks; female Balb/c mice) treatment reduces joint damage. Pralnacasan treatment does not appear to affect the weight of the animals[1]. Animal Model: Female Balb/c mice induced with collagenase[1] Dosage: 0 mg/kg, 12.5 mg/kg, 25 mg/kg and 50 mg/kg Administration: Oral gavage; twice a day; for 6 weeks Result: Significantly ameliorated the histopathological damage of the medial knee joint compartments.

[References]

[1]. Rudolphi K, et al. Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage. 2003 Oct;11(10):738-46.

[2]. Loher F, et al. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. J Pharmacol Exp Ther. 2004 Feb;308(2):583-90.

Chemical & Physical Properties

[ Density]:
1.44g/cm3

[ Molecular Formula ]:
C₂₆H₂₉N₅O₇

[ Molecular Weight ]:
523.53800

[ Exact Mass ]:
523.20700

[ PSA ]:
150.73000

[ LogP ]:
1.76290

[ Index of Refraction ]:
1.657

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.